October 26th, 2012|
October 26, 2012
Ohio is set to receive a large portion of a settlement that was reached in connection to a lawsuit filed against drug manufacturing giant, Boehringer Ingelheim Pharmaceuticals Inc. (BIPI). The Dayton Business Journal reports the lawsuit was filed amid allegations the company had engaged in illegal marketing campaigns for certain medications and was also involved in a kickback scheme when it gave millions of dollars to doctors in return for prescribing the company’s medications.
Court documents allege that BIPI began to use off-label marketing techniques, or using a drug to treat a condition for which it’s not approved. Some of those medications include:
The lawsuit also claims representatives for the company urged doctors to prescribe the medications at higher doses than were approved by the FDA, which could have led to a serious Ohio Drug Injury. The company also is accused of offering doctors incentives for prescribing the drugs to patients.
The settlement in the lawsuit was reached earlier this week and Ohio’s Attorney General, Mike DeWine, says the state should see roughly $1.4 million. The federal government will receive a large chunk of the settlement as well, mainly to cover overpayments that were made to Medicaid.
The Ohio Personal Injury Lawyers with Nurenberg, Paris, Heller & McCarthy are hopeful the settlement will prevent other companies from attempting similar business practices that can put a patient’s health and safety in serious danger.